616 The impact of zoledronic acid to PSA, bone lesions and quality of life of patients with hormone refractory metastatic prostate cancer

✍ Scribed by D. Liapis; A. Argyropoulos; A. Kalantzis; G. Vasilakis; G. Papadopoulos; A. Fragulis; I. Liakatas; M. Lykourinas

• Book ID: 118645822
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 225 KB
• Volume: 3
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/s1569-9056(04)90610-0